Terms: = Thyroid cancer AND CTCF, P49711, 10664, ENSG00000102974
9 results:
1. Telocinobufagin, a PLK1 suppressor that inhibits tumor growth and metastasis by modulating CDC25c and ctcf in HNSCC cells.
Li J; Ma R; Lv JL; Ren YS; Tan YJ; Wang HM; Wang ZE; Wang BS; Yu JN; Wang YL; Tian J; Zheng QS
Phytomedicine; 2024 May; 127():155440. PubMed ID: 38452691
[TBL] [Abstract] [Full Text] [Related]
2. Epigenetic inhibition of ctcf by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer.
Pan Z; Lu X; Xu T; Chen J; Bao L; Li Y; Gong Y; Che Y; Zou X; Tan Z; Huang P; Ge M
Cancer Lett; 2024 Jan; 580():216496. PubMed ID: 37993084
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein.
Cai Z; Shi Q; Li Y; Jin L; Li S; Wong LL; Wang J; Jiang X; Zhu M; Lin J; Wang Q; Yang W; Liu Y; Zhang J; Gong C; Yao H; Yao Y; Liu Q
Sci Adv; 2023 Oct; 9(40):eadi3821. PubMed ID: 37801505
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.
Zhang L; Sun S; Zhao X; Liu J; Xu Y; Xu L; Song C; Li N; Yu J; Zhao S; Yu P; Fang F; Xie J; Ji X; Yu R; Ou Q; Zhao Z; Li M
Mol Oncol; 2022 Oct; 16(20):3689-3702. PubMed ID: 35971249
[TBL] [Abstract] [Full Text] [Related]
5. ctcf-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast cancer via Sponging miR-149-5p to Up-Regulate ctcf and CTNNB1 to Activate Wnt/β-Catenin Pathway.
Zhu S; Sun J; Liu X; Shao H; Feng C; Wang Z; Zheng X; Wei S
Mol Cell Biol; 2022 Jun; 42(6):e0018821. PubMed ID: 35499320
[TBL] [Abstract] [Full Text] [Related]
6. Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility.
Atkin ND; Raimer HM; Wang YH
Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31614754
[TBL] [Abstract] [Full Text] [Related]
7. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
8. COUP-TFII is a modulator of cell-type-specific genetic programs based on genomic localization maps.
Erdős E; Bálint BL
J Biotechnol; 2019 Aug; 301():11-17. PubMed ID: 31158411
[TBL] [Abstract] [Full Text] [Related]
9. Negative transcriptional regulation mediated by thyroid hormone response element 144 requires binding of the multivalent factor ctcf to a novel target DNA sequence.
Awad TA; Bigler J; Ulmer JE; Hu YJ; Moore JM; Lutz M; Neiman PE; Collins SJ; Renkawitz R; Lobanenkov VV; Filippova GN
J Biol Chem; 1999 Sep; 274(38):27092-8. PubMed ID: 10480923
[TBL] [Abstract] [Full Text] [Related]
